Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/12/2005 | EP0793723B1 New staphylokinase derivatives |
10/12/2005 | EP0669979B1 C-c ckr-1, c-c chemokine receptor |
10/12/2005 | EP0556345B2 Retroviral vectors useful for gene therapy |
10/12/2005 | CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
10/12/2005 | CN1681846A Process for producing hydroxyalkyl starch derivatives |
10/12/2005 | CN1681844A Hasylated polypeptides, especially hasylated erythropoietin |
10/12/2005 | CN1681843A Parathyroid hormone-like polypeptides |
10/12/2005 | CN1681839A Proline ester and preparation containing the same for percutaneous administration |
10/12/2005 | CN1681836A Targeting proteins to deliver therapeutic or diagnostic reagents |
10/12/2005 | CN1681540A Metal implant coated under reduced oxygen concentration with osteoinductive protein |
10/12/2005 | CN1681532A Therapeutics for diabetes mellitus |
10/12/2005 | CN1681528A Use of urease for inhibiting cancer cell growth |
10/12/2005 | CN1681527A Therapies for renal failure using interferon-beta |
10/12/2005 | CN1681526A Use of erythropoietin |
10/12/2005 | CN1681525A A method for inhibiting vascular permeability and tissue edema |
10/12/2005 | CN1681524A Body fat percentage-lowering agent or body fat percentage increase inhibitor |
10/12/2005 | CN1681518A Combination therapies with L-FMAU for the treatment of hepatitis b virus infection |
10/12/2005 | CN1681517A Peptide boronic acids useful in making salts thereof |
10/12/2005 | CN1681500A Topical treatment of skin diseases |
10/12/2005 | CN1681473A Skin depigmenting compositions comprising adapalene and at least one depigmenting active agent |
10/12/2005 | CN1680578A Preparation of oyster bioactive peptide |
10/12/2005 | CN1680566A Pseudomycin production by pseudomonas syringae |
10/12/2005 | CN1680557A Penicillium marneffei CRG5 gene, its coding protein and use |
10/12/2005 | CN1680555A Penicillium marneffei 60S ribosomal protein L33-B, its coding sequence and use |
10/12/2005 | CN1680554A Penicillium marneffei thymus resistant glubolin, its coding sequence and use |
10/12/2005 | CN1680553A Penicillium marneffei 40S ribosomal protein S28, its coding sequence and use |
10/12/2005 | CN1680551A Gene of regulating epithelial cell channel of small intestine and its preparation and use |
10/12/2005 | CN1680449A Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol |
10/12/2005 | CN1680448A Macrogol-interferon, preparation and use thereof |
10/12/2005 | CN1680447A Neutralizing high affinity human monoclonal antibodies specific to respiratory syncytial virus f-protein |
10/12/2005 | CN1680443A Recombinat protein containing albumin multimer |
10/12/2005 | CN1680442A Truncated VEGF-related proteins |
10/12/2005 | CN1680440A Batyl active peptide, preparation and therepic use thereof |
10/12/2005 | CN1680438A Human pifl gene, its coding protein and use thereof |
10/12/2005 | CN1680434A Streptococcus pneumoniae antigens |
10/12/2005 | CN1680432A Viral protein |
10/12/2005 | CN1680431A Crystal of human avidin protein and preparation thereof |
10/12/2005 | CN1680427A Water soluble piduomode composite salt and its preparation |
10/12/2005 | CN1680402A Water soluble prodrugs of hindered alcohols |
10/12/2005 | CN1679938A Pharmaceutical compositions |
10/12/2005 | CN1679934A Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
10/12/2005 | CN1679929A Streptococcal c5a peptidase vaccine |
10/12/2005 | CN1679927A Use of human lysozyme in preparing medicines for cutaneous pruritus |
10/12/2005 | CN1679926A Use of human lysozyme in preparing anti-virus medicines for influenza |
10/12/2005 | CN1679925A Sustained releasing microspheric preparation of glucokinase mutant and its making method |
10/12/2005 | CN1679924A Compound insulin energy mistura preparation and use thereof |
10/12/2005 | CN1679923A Oral enteric-coated microsphere of Thymosin and preparation thereof |
10/12/2005 | CN1679922A Gonadoliberin genital regulating medicine with double ways and reproduction of animals |
10/12/2005 | CN1679921A Gonadoliberin genital regulating medicine with double ways and reproduction of fish |
10/12/2005 | CN1679920A Gonadoliberin genital regulating medicine with double ways and reproduction of fishes, birds and animals |
10/12/2005 | CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist |
10/12/2005 | CN1679918A Medical use of interleukin-22 |
10/12/2005 | CN1679917A Oil-free pharmaceutical compositions containing cyclosporin A |
10/12/2005 | CN1679916A Pharmaceutical compositions |
10/12/2005 | CN1679915A Peptide antagonists of zonulin and methods for use of the same |
10/12/2005 | CN1679914A Medicinal composition of induced glutathione and ebeselen |
10/12/2005 | CN1679798A Biological medicine with metabolic treatment and production thereof |
10/12/2005 | CN1679612A Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity |
10/12/2005 | CN1679556A Valdecoxib compositions |
10/12/2005 | CN1679504A Use of human lysozyme in cosmetics for treating acne |
10/12/2005 | CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies |
10/12/2005 | CN1222616C Novel human protein with cancer-inhibiting function and coding sequence thereof |
10/12/2005 | CN1222540C Monoclonal antibodies anti-CD6 and their uses |
10/12/2005 | CN1222539C Human receptor proteins, related reagents and methods |
10/12/2005 | CN1222538C Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
10/12/2005 | CN1222536C Prevention and treatment of hepatocellular cancer |
10/12/2005 | CN1222374C Extrusion die |
10/12/2005 | CN1222315C Stable liquid interferon formulations |
10/12/2005 | CN1222312C Fibrin ferment hemostatic suppository |
10/12/2005 | CN1222311C Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
10/12/2005 | CN1222310C Preparation for administration of hepatocyte growth factor |
10/12/2005 | CN1222218C Method for producing granulates contg. enzymes |
10/11/2005 | USRE38828 Parevins and tachytegrins |
10/11/2005 | US6953861 Method of re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide |
10/11/2005 | US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS |
10/11/2005 | US6953847 Fas antigen derivative |
10/11/2005 | US6953843 Antibodies and fragments thereof to MDL-1 protein |
10/11/2005 | US6953842 Antibodies to heregulin 2 |
10/11/2005 | US6953840 Methods of using non-human animal Apolipoprotein A-I protein |
10/11/2005 | US6953838 Urocortin-III and uses thereof |
10/11/2005 | US6953837 Factor VIII/vWF complexes and compositions |
10/11/2005 | US6953834 Transcription factors related to TFIIA |
10/11/2005 | US6953833 Cyclic peptide; for use in prevention of bacterial infection |
10/11/2005 | US6953791 Dipeptide derivatives |
10/11/2005 | US6953783 Modulation of gene expression by combination therapy |
10/11/2005 | US6953780 Endothelin antagonist |
10/11/2005 | US6953779 Administering oligopeptide |
10/11/2005 | US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
10/11/2005 | US6953777 Use of interleukin-11 to prevent immune-mediated cytotoxicity |
10/11/2005 | US6953776 Ophthalmic formulations |
10/11/2005 | US6953775 Composition for synthetic cervical mucus formulation |
10/11/2005 | US6953774 Administration of a non-polypeptide cAMP level modulator to host |
10/11/2005 | US6953691 A vector codes domain, antibodies, for modulating NF kappa B protein transcriptional activity, antiapoptosis |
10/11/2005 | US6953683 Compositions and methods of inhibiting bacterial spore germination |
10/11/2005 | US6953681 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
10/11/2005 | US6953674 Inhibitors of human plasmin derived from the kunitz domains |
10/11/2005 | US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin |
10/11/2005 | US6953667 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease |
10/11/2005 | US6953662 Follistatin-3 |
10/11/2005 | US6953661 Method of preventing transport of a neurotropic virus and identifying agents for achieving same |